Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201107023 Principal Investigator: Linette, Gerald
Title: A Phase II, randomized double-blind study of efficacy and safety of two dose levels of LDE225 in patients with locally advanced or metastatic basal cell carcinoma
Phase: II Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this clinical research study is to find out if the drug LDE225 is safe and has beneficial effects in people who have basal cell carcinoma (skin cancer),
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)